Safety and efficacy of topical steroid administration in patients undergoing mandibular horizontal impacted wisdom tooth extractio

Phase 2

Recruiting

• Conditions: mandibular horizontal impacted wisdom tooth

• Registration Number: JPRN-jRCTs071210140
• Lead Sponsor: aruse Tomofumi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 246

Inclusion Criteria

1. patients who are planned to undergo mandibular horizontal impacted wisdom tooth extraction
2. Patients who can personally provide written consent at their own free will after being receiving a thorough explanation of the study and fully understanding their participation in the study.

Exclusion Criteria

Any of the following patients will be excluded:
1. Patients with problem in judgement.
2. Patients receiving therapies with anti-resorption drugs.
3. Patients with a history of radiation therapy to the jawbone.
4. Patients are immunocompromised with steroid or immunosuppressants.
5. Patients receiving therapies with antithrombotic therapy.
6. Patients for whom administration of Sol-Corteph, Spongel, Amoxicillin, Loxoprofen Sodium Hydrate or Acetaminophen is contraindicated.
7. Patients receiving therapies with Desmopressin Acetate Hydrate
8. Patients who receive analgesics for pain at least once a week (e.g., cancer pain, non-cancer pain). However, topical analgesics and anti-inflammatory drugs (patches and applications) are allowed.
9. Women who are or may be pregnant or lactating women.
10. Partients who are judged to be inappropriate to participate the study by the principal or cooperative doctors.

Study & Design

• Study Type: Interventional
• Study Design: Not specified